FDA Approved: EYE ALLERGY RELIEF — Supplemental Application (DOLGENCORP, LLC)

View source ↗

Summary

FDA approved a supplemental application for Eye Allergy Relief (pheniramine maleate and naphazoline hydrochloride) from DolgenCorp, LLC under NDA020065.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE)

Snippet

SUPPL AP for EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE)